Fig. 3From: Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adultsTime taken to achieve virologic suppression. RPV rilpivirine, EFV efavirenz, PI protease inhibitor, ART anti-retroviral therapy, VL40 viral load < 40 copies/mlBack to article page